Oncoinvent A

Oncoinvent A FCF Yield

The Free Cash Flow Yield of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -68.19 %. In the previous year, Free Cash Flow Yield was -80.52 % — a change of -15.31% (higher).

FCF Yield

-68.19 %

YoY

-15.31%

Last updated:

Free Cash Flow Yield of Oncoinvent A is 2025 -68.19 % . Free Cash Flow Yield of Oncoinvent A was 2024 -80.52 % . It decreases by -15.31% higher compared to the previous year.

The Oncoinvent A FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-97.08 NOK
Jan 1, 2019
-96.95 NOK
Jan 1, 2020
-121.71 NOK
Jan 1, 2021
-157.54 NOK
Jan 1, 2022
-151.76 NOK
Jan 1, 2023
-85.66 NOK
Jan 1, 2024
-80.52 NOK
Jan 1, 2025
-68.19 NOK
The Oncoinvent A FCF Yield history
YEARFCF YieldYoY
-68.19 %-15.31%
-80.52 %-6.00%
-85.66 %-43.55%
-151.76 %-3.67%
-157.54 %+29.44%
-121.71 %+25.54%
-96.95 %-0.13%
-97.08 %+10.97%
-87.48 %+35.22%
-64.70 %+98.04%
-32.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

Free Cash Flow Yield of Oncoinvent A is -68.19 % in 2025.

Free Cash Flow Yield of Oncoinvent A changed from -80.52 % to -68.19 %, representing a -15.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Oncoinvent A with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Oncoinvent A

All Key Metrics — Oncoinvent A